DK355189D0 - Nye proteiner - Google Patents

Nye proteiner

Info

Publication number
DK355189D0
DK355189D0 DK355189A DK355189A DK355189D0 DK 355189 D0 DK355189 D0 DK 355189D0 DK 355189 A DK355189 A DK 355189A DK 355189 A DK355189 A DK 355189A DK 355189 D0 DK355189 D0 DK 355189D0
Authority
DK
Denmark
Prior art keywords
new proteins
proteins
new
Prior art date
Application number
DK355189A
Other languages
English (en)
Other versions
DK355189A (da
Inventor
Andrew Wallace
Stanley Dennis
Jan Hofsteenge
Stuart R Stone
Original Assignee
Ciba Geigy Ag
Ucp Gen Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag, Ucp Gen Pharma Ag filed Critical Ciba Geigy Ag
Publication of DK355189D0 publication Critical patent/DK355189D0/da
Publication of DK355189A publication Critical patent/DK355189A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK355189A 1988-07-19 1989-07-18 Nye proteiner DK355189A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888817160A GB8817160D0 (en) 1988-07-19 1988-07-19 Novel proteins

Publications (2)

Publication Number Publication Date
DK355189D0 true DK355189D0 (da) 1989-07-18
DK355189A DK355189A (da) 1990-01-20

Family

ID=10640714

Family Applications (1)

Application Number Title Priority Date Filing Date
DK355189A DK355189A (da) 1988-07-19 1989-07-18 Nye proteiner

Country Status (13)

Country Link
EP (1) EP0352228A3 (da)
JP (1) JPH02117694A (da)
KR (1) KR900001848A (da)
AU (1) AU3804589A (da)
DD (1) DD284045A5 (da)
DK (1) DK355189A (da)
FI (1) FI893451A7 (da)
GB (1) GB8817160D0 (da)
HU (1) HUT51671A (da)
IL (1) IL91003A0 (da)
NO (1) NO892949L (da)
PT (1) PT91190A (da)
ZA (1) ZA895460B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614121B2 (en) * 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
GB9010552D0 (en) * 1990-05-10 1990-07-04 Erba Carlo Spa Method for the recombinant production of hirudins and novel hirudins
US6060451A (en) * 1990-06-15 2000-05-09 The National Research Council Of Canada Thrombin inhibitors based on the amino acid sequence of hirudin
US6514730B1 (en) 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
NZ336793A (en) * 1997-01-20 2000-08-25 Japan Energy Corp Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture
EP1597279A1 (en) * 2003-02-27 2005-11-23 National Research Council Of Canada Peptide inhibitors of thrombin as potent anticoagulants
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583361D1 (de) * 1984-06-14 1991-08-08 Ucp Gen Pharma Ag Verfahren zur herstellung von thrombin-inhibitoren.
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu

Also Published As

Publication number Publication date
FI893451L (fi) 1990-01-20
NO892949D0 (no) 1989-07-18
NO892949L (no) 1990-01-22
EP0352228A2 (en) 1990-01-24
FI893451A0 (fi) 1989-07-17
HUT51671A (en) 1990-05-28
ZA895460B (en) 1990-02-28
FI893451A7 (fi) 1990-01-20
DK355189A (da) 1990-01-20
EP0352228A3 (en) 1990-07-11
GB8817160D0 (en) 1988-08-24
IL91003A0 (en) 1990-02-09
JPH02117694A (ja) 1990-05-02
PT91190A (pt) 1990-02-08
AU3804589A (en) 1990-01-25
DD284045A5 (de) 1990-10-31
KR900001848A (ko) 1990-02-27

Similar Documents

Publication Publication Date Title
DK257988D0 (da) Nye peptider
DK540289D0 (da) Protein
DK55889D0 (da) Substituerede pyrroler
DK355189D0 (da) Nye proteiner
DK616889D0 (da) Nye alfa-cyano-beta-oxopropionamider
DK395288D0 (da) Proteiner
DK578389A (da) Substituerede oxadiaminobutaner
FI912412A7 (fi) HDL-sitovat proteiinit
DK354989D0 (da) Modificerede proteiner
DK284489D0 (da) Fusionsproteiner
DK429689A (da) Substituerede pyridazinoner
KR900004589U (ko) 장기
ATA296888A (de) Labyrinthanordnung
DK312488D0 (da) Nye peptider
DK611387D0 (da) Nye peptidderivater
DK344887D0 (da) Nye peptider
DK344987D0 (da) Nye peptider
NO874091L (no) Nye trombolytiske proteiner.
NO921024D0 (no) Nye lymfokin-relaterte peptider
DK477789D0 (da) Nye polypeptider
DK113485D0 (da) Nye peptider
BR1100729A (pt) Polipeptìdeo modificado
BR6801369U (pt) Lacre rapido
DK408389D0 (da) Novel protein derivatives
DK204389A (da) Angiogent protein

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment